Coherus Oncology (CHRS) Inventory (2018 - 2026)
Coherus Oncology (CHRS) posted Inventory of $4.8 million for Q1 2026, up 52.11% sequentially from $3.2 million in Q4 2025, and up 37.15% YoY from $3.5 million in Q1 2025.
Coherus Oncology (CHRS) Inventory (2018 - 2026) Analysis & Trends
Coherus Oncology has reported Inventory for 9 years, with the latest figure at $4.8 million in Q1 2026.
- Quarterly Inventory rose 37.15% year-over-year to $4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.8 million (up 37.15% YoY) and the FY2025 annual result came in at $3.2 million, down 24.6% from the prior year.
- Inventory improved to $4.8 million in Q1 2026 per CHRS's latest filing, from $3.2 million in the prior quarter.
- Over five years, Inventory peaked at $66.8 million in Q3 2023 and troughed at $2.0 million in Q3 2025.
- A 5-year average of $33.6 million and a median of $36.9 million in 2022 frame the typical range for Inventory.
- The sharpest annual moves came in 2023 and 2025: Inventory jumped 140.93% in 2023, then tumbled 95.7% in 2025.
- Over 5 years, Inventory stood at $38.8 million in 2022, then surged by 61.39% to $62.6 million in 2023, then tumbled by 93.28% to $4.2 million in 2024, then slipped by 24.6% to $3.2 million in 2025, then surged by 52.11% to $4.8 million in 2026.
- According to Business Quant data, Inventory over the past three periods registered $4.8 million, $3.2 million, and $2.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.53 Bn | 130.68 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 86.34 Bn | 78.35 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.67 Bn | 59.48 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 59.04 Bn | 53.90 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.94 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 30.78 Bn | 27.47 Bn | 992.69 Mn | 97.11 Mn |
| 7 | BioNTech SE | 27.81 Bn | 9.42 Bn | 668.28 Mn | 128.86 Mn |
| 8 | Insmed | 27.21 Bn | 26.05 Bn | 358.27 Mn | 142.38 Mn |
| 9 | Royalty Pharma | 26.99 Bn | 26.15 Bn | - | - |
| 10 | Coherus Oncology | 210.55 Mn | 105.25 Mn | 10.07 Mn | 5.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.67 Mn |
| Mar 31, 2026 | 4.83 Mn |
| Dec 31, 2025 | 3.17 Mn |
| Sep 30, 2025 | 2.05 Mn |
| Jun 30, 2025 | 4.51 Mn |
| Mar 31, 2025 | 3.52 Mn |
| Dec 31, 2024 | 4.21 Mn |
| Sep 30, 2024 | 47.64 Mn |
| Jun 30, 2024 | 62.16 Mn |
| Mar 31, 2024 | 61.98 Mn |
| Dec 31, 2023 | 62.61 Mn |
| Sep 30, 2023 | 66.78 Mn |
| Jun 30, 2023 | 63.99 Mn |
| Mar 31, 2023 | 49.41 Mn |
| Dec 31, 2022 | 38.79 Mn |
| Sep 30, 2022 | 27.72 Mn |
| Jun 30, 2022 | 31.74 Mn |
| Mar 31, 2022 | 36.95 Mn |
| Dec 31, 2021 | 37.64 Mn |
| Sep 30, 2021 | 37.58 Mn |